Upon internal review on 10-Jun-2016, the case was identified as duplicate of 2016SA049383, hence all the 
information pertaining to this case have been merged from this case to case ID: 2016SA049383.
This case is cross referenced with 2016SA049383 (duplicate).
This unsolicited case was received from United States on 07-Mar-2016 from a physician.
This case involves a 7 year old female patient who started treatment with eliglustat (Cerdelga) and developed 
avascular necrosis (AVN) in right femur and fracture.
Patient was diagnosed with Gaucher Disease in Feb-2014 and started Vpriv enzyme replacement therapy on 10-
Print Time: 15-JUL-2016 02:35 PM If a field is blank, there is no data for that field Page 490 of 517
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
Mar-2014. Patient developed pan-reactive neutralizing antibodies on VPRIV enzyme replacement therapy and in 
Nov-2015, developed left femur AVN. Concomitant medications included naproxen, hydromorphone, omeprazole 
(Prilosec), paracetamol (Tylenol), hyoscine (Scopolamine), imiglucerase (Cerezyme), methylprednisolone sodium 
succinate (Solumedrol), diphenhydramine hydrochloride (Benadryl) and lidocaine/tetracaine (Synera). No 
concurrent conditions were reported.
The patient started to develop severe right femur pain on 10-Feb-2016 consistent with the new AVN. On 15-Feb-
2016, the patient started treatment with oral eliglustat daily at a dose of 42 mg twice daily (form, batch number and 
expiry date: unknown) for Gaucher's disease. On 21-Feb-2016, the patient underwent magnetic resonance imaging
(MRI), which confirmed new AVN in right femur. On an unknown date, the patient experienced fracture. On (b) (6)
 the patient underwent a surgical procedure to put a pin in her left hip to fix the fracture, as well as core drilling
in bilateral femur for relieving pain.
Action taken: unknown
Corrective treatment: surgery (pin placement in left hip to fix the fracture) for fracture
Outcome: unknown for both the events
Seriousness criteria: Hospitalization or prolongation (hospitalization date: unknown) for both the events
Upon internal review on 10-Jun-2016, the case was identified as duplicate of 2016SA049383, hence all the 
information pertaining to this case have been merged from this case to case ID: 2016SA049383.